- Trials with a EudraCT protocol (44,349)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
44,349 result(s) found.
Displaying page 196 of 2,218.
EudraCT Number: 2008-002855-26 | Sponsor Protocol Number: Droxidopa-301 | Start Date*: 2008-10-01 |
Sponsor Name:Chelsea Therapeutics Inc | ||
Full Title: A Multi-Centre, Double-Blind, Placebo-Controlled, Parallel-Group Induction-Design Study to assess the Clinical Effect of Droxidopa in Subjects with Primary Autonomic Failure, Dopamine Beta Hydroxyl... | ||
Medical condition: Symptomatic neurogenic orthostatic hypotension (NOH) in patients with Primary Autonomic Failure (Pharmacodynamic, MSA and PAF), DBH deficiency and Non-Diabetic Neuropathy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) CZ (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-005050-31 | Sponsor Protocol Number: IR103-112 | Start Date*: 2005-07-21 |
Sponsor Name:THE IMMUNE RESPONSE CORPORATION | ||
Full Title: A safety and Immunogenicity Study of IR103 HIV-1 Antigen plus Amplivax TM in IFA Comapared to Remune R HIV-1 antigen in IFA in Antiretroviral Naive HIV-1 Infected Subjects | ||
Medical condition: agent able to generate HIV-specific immune responses in antiretroviral naive HIV infected subjects. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005055-33 | Sponsor Protocol Number: ML17443 | Start Date*: 2005-09-01 | |||||||||||
Sponsor Name:Barts and the London NHS Trust | |||||||||||||
Full Title: Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay ... | |||||||||||||
Medical condition: Renal Transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012602-39 | Sponsor Protocol Number: 05-NEOV-002 | Start Date*: 2010-05-17 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: A randomised, double-blind study evaluating the safety, tolerability, protein accretion, amino acid plasma levels and long-term outcome of Neoven compared to Vaminolact(R) in premature very low bir... | |||||||||||||
Medical condition: The product is aimed to be used where parenteral nutrition is required. The intended indication is: Supply of essential and non-essential amino acids as part of parenteral nutrition for premature ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012608-20 | Sponsor Protocol Number: NeoFLOT-2-Studie | Start Date*: 2010-01-29 | |||||||||||
Sponsor Name:An-Institut für Qualitätssicherung in der operativen Medizin gGmbH | |||||||||||||
Full Title: Phase II-Studie zur Erfassung der Wirksamkeit einer neoadjuvanten Chemotherapie mit 5-FU/ Leucovorin/ Oxaliplatin/ Docetaxel beim lokal fortgeschrittenen Adenokarzinom des Magens oder des gastroös... | |||||||||||||
Medical condition: lokal fortgeschrittenes Adenokarzinom des Magens oder des gastroösophagalen Übergangs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012614-48 | Sponsor Protocol Number: H3B110651 | Start Date*: 2009-10-26 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of the H3 receptor antagonist, GSK239512 in subjects with mild to moderate Alzheimer’s disease. | |||||||||||||
Medical condition: Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) CZ (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006177-88 | Sponsor Protocol Number: FARM65KNKY | Start Date*: 2008-01-24 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||
Full Title: A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years where thrombolysis is initiated within 3 hours afte... | |||||||||||||
Medical condition: acute ischemic stroke | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016716-20 | Sponsor Protocol Number: 08/152/WRI | Start Date*: 2010-03-03 | |||||||||||||||||||||
Sponsor Name:Brighton and Sussex University Hospitals NHS Trust | |||||||||||||||||||||||
Full Title: Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling | |||||||||||||||||||||||
Medical condition: Depression | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016720-31 | Sponsor Protocol Number: 250901 | Start Date*: 2010-06-09 | |||||||||||
Sponsor Name:Baxter Innovations GmbH [...] | |||||||||||||
Full Title: BAX 326 (recombinant Factor IX): A Phase 1/3 Prospective, Controlled, Multicenter Study Evaluating Pharmacokinetics, Efficacy, Safety, Immunogenicity in Previously Treated Patients with Severe (FIX... | |||||||||||||
Medical condition: Previously treated patients with severe (FIX level < 1%) or moderately severe (FIX level ≤ 2%) hemophilia B. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) CZ (Completed) ES (Completed) BG (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011926-32 | Sponsor Protocol Number: ALF-BID-1108 | Start Date*: 2009-10-21 |
Sponsor Name:Exalenz Bioscience Ltd [...] | ||
Full Title: Breath Test for Patients with Acute Liver Disease for early Detection of the Need for Transplant or Recovery | ||
Medical condition: The study will look at the liver metabolic function in patients with acute liver failure. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022215-19 | Sponsor Protocol Number: GHIGF1/2011 | Start Date*: 2011-07-21 | |||||||||||
Sponsor Name:Greater Glasgow & Clyde NHS | |||||||||||||
Full Title: A Pharmacokinetic Study Of The Combined Use Of Recombinant Human GH And IGF-1 In Children With Inflammatory Bowel (Crohn’s) Disease | |||||||||||||
Medical condition: Impaired growth in Paediatric Crohn's disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000536-40 | Sponsor Protocol Number: BAY38-9456/12093 | Start Date*: 2008-03-29 | |||||||||||
Sponsor Name:Bayer HealthCare AG, D-51368 Leverkusen, Germany | |||||||||||||
Full Title: Pivotal phase III trial to investigate the efficacy and safety of an Orodispersible Tablet vardenafil versus placebo in the treatment of men with Erectile dysfunction (ED) - a fixed-dose, double-bl... | |||||||||||||
Medical condition: Erectile Dysfunction (ED) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) BE (Completed) DE (Completed) FR (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-010594-20 | Sponsor Protocol Number: P 0901 | Start Date*: 2010-04-13 |
Sponsor Name:LUMC | ||
Full Title: Thoracic epidural anesthesia with ropivacaine: effects of age on neural blockade and cardiovascular parameters | ||
Medical condition: Medical conditions will not be investigated per se, however we will study the effect of standard thoracic epidural anesthesia on specific age groups undergoing lung surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024196-83 | Sponsor Protocol Number: CF101-202PS | Start Date*: 2011-03-29 | |||||||||||
Sponsor Name:Can-Fite BioPharma, Ltd. | |||||||||||||
Full Title: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of the Efficacy and Safety of Daily CF101 Administered Orally in Patients with Moderate-to-Severe Plaque Psoriasis | |||||||||||||
Medical condition: Moderate-to-Severe Plaque Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019685-87 | Sponsor Protocol Number: RO-2455-404-RD | Start Date*: 2011-04-27 | |||||||||||
Sponsor Name:Takeda Pharma A/S | |||||||||||||
Full Title: Effect of roflumilast on exacerbation rate in patients with COPD treated with fixed combinations of LABA and ICS. A 52-week, randomised double-blind trial with roflumilast 500 μg versus placebo | |||||||||||||
Medical condition: severe chronic obstructive pulmonary disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) BE (Completed) DE (Completed) AT (Completed) DK (Completed) GR (Completed) NL (Completed) HU (Completed) SK (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019695-76 | Sponsor Protocol Number: MKI113006 | Start Date*: 2010-11-11 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development | |||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice Daily compar... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006342-25 | Sponsor Protocol Number: HM08 / 8625 | Start Date*: 2009-02-09 | |||||||||||
Sponsor Name:Leeds Teaching Hospitals NHS Trust | |||||||||||||
Full Title: ADMIRE: Does the ADdition of Mitoxantrone Improve REsponse to FCR chemotherapy in patients with CLL: A randomised Phase II Trial of fludarabine, cyclophosphamide and rituximab (FCR) with or withou... | |||||||||||||
Medical condition: Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012457-37 | Sponsor Protocol Number: 913-002 | Start Date*: 2009-08-13 | |||||||||||
Sponsor Name:Vantia Ltd | |||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Cross-Over Proof of Concept Study to Investigate the Efficacy and Safety of Pre-Emptive Administration of Repeated, Oral Doses of VA1119... | |||||||||||||
Medical condition: Dysmenorrhoea | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012752-24 | Sponsor Protocol Number: RG_09-016 | Start Date*: 2010-06-23 |
Sponsor Name:University of Birmingham [...] | ||
Full Title: High or Low Dose Syntocinon (Oxytocin) for delay in labour | ||
Medical condition: Approximately a third of women become delayed in their first labours and are given intravenous oxytocin in an attempt to increase their uterine contractions and thereby increase spontaneous vaginal... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018254-12 | Sponsor Protocol Number: A0221090 | Start Date*: 2010-03-16 | |||||||||||
Sponsor Name:Pfizer, Inc | |||||||||||||
Full Title: A LOCAL, MULTICENTRE, OPEN-LABEL, EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF FESOTERODINE FLEXIBLE DOSE REGIMEN IN ELDERLY PATIENTS WITH OVERACTIVE BLADDER | |||||||||||||
Medical condition: Treatment of overactive bladder with symptoms of frequency, urgency, and urgency incontinence (Some patients will also have urgency urinary incontinence (UUI)). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
